Segui
Kurt Selle
Kurt Selle
Affiliazione sconosciuta
Email verificata su ncsu.edu
Titolo
Citata da
Citata da
Anno
Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems
AA Gomaa, HE Klumpe, ML Luo, K Selle, R Barrangou, CL Beisel
MBio 5 (1), 10.1128/mbio. 00928-13, 2014
5052014
Guide RNA functional modules direct Cas9 activity and orthogonality
AE Briner, PD Donohoue, AA Gomaa, K Selle, EM Slorach, CH Nye, ...
Molecular cell 56 (2), 333-339, 2014
4072014
Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health
K Selle, TR Klaenhammer
FEMS microbiology reviews 37 (6), 915-935, 2013
2642013
Harnessing CRISPR–Cas systems for bacterial genome editing
K Selle, R Barrangou
Trends in microbiology 23 (4), 225-232, 2015
2432015
In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
K Selle, JR Fletcher, H Tuson, DS Schmitt, L McMillan, GS Vridhambal, ...
MBio 11 (2), 10.1128/mbio. 00019-20, 2020
1702020
Methods and compositions for sequence guiding Cas9 targeting
R Barrangou, KM Selle, AE Briner
US Patent 10,787,654, 2020
1672020
SIGNR3-dependent immune regulation by Lactobacillus acidophilus surface layer protein A in colitis
MM Lightfoot YL, Selle K, Yang T, Goh YJ, Sahay B, Zadeh M, Owen JL, Colliou ...
Embo Journal, 2015
1512015
CRISPR-based screening of genomic island excision events in bacteria
K Selle, TR Klaenhammer, R Barrangou
Proceedings of the National Academy of Sciences 112 (26), 8076-8081, 2015
1452015
Identification of extracellular surface-layer associated proteins in Lactobacillus acidophilus NCFM
B Johnson, K Selle, S O’Flaherty, YJ Goh, T Klaenhammer
Microbiology 159 (Pt_11), 2269-2282, 2013
1332013
Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids
R Barrangou, KM Selle
US Patent 10,136,649, 2018
992018
CRISPR‐Based technologies and the future of food science
K Selle, R Barrangou
Journal of food science 80 (11), R2367-R2372, 2015
712015
Occurrence and activity of a type II CRISPR-Cas system in Lactobacillus gasseri
R Sanozky-Dawes, K Selle, S O'Flaherty, T Klaenhammer, R Barrangou
Microbiology 161 (9), 1752-1761, 2015
582015
Sortase-deficient lactobacilli: effect on immunomodulation and gut retention
EK Call, YJ Goh, K Selle, TR Klaenhammer, S O’Flaherty
Microbiology 161 (2), 311-321, 2015
582015
Outcomes and characterization of chromosomal self-targeting by native CRISPR-Cas systems in Streptococcus thermophilus
C Cañez, K Selle, YJ Goh, R Barrangou
FEMS microbiology letters 366 (9), fnz105, 2019
482019
Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid
M Zadeh, MW Khan, YJ Goh, K Selle, JL Owen, T Klaenhammer, ...
Journal of inflammation 9, 1-12, 2012
422012
In vivo targeting of Clostridioides difficile using phage-delivered CRISPR-Cas3 antimicrobials. mBio 11: e00019-20
K Selle, JR Fletcher, H Tuson, DS Schmitt, L McMillan, GS Vridhambal, ...
272020
LACTOBACILLUS| Lactobacillus acidophilus
KM Selle, TR Klaenhammer, WM Russell
Academic Press, 2014
192014
Methods and compositions for killing a target bacterium
PM Garofolo, DG Ousterout, K Selle, W Sandi, HH Tuson
US Patent App. 16/899,436, 2020
172020
Deletion of Lipoteichoic Acid Synthase Impacts Expression of Genes Encoding Cell Surface Proteins in Lactobacillus acidophilus
K Selle, YJ Goh, BR Johnson, S O’Flaherty, JM Andersen, R Barrangou, ...
Frontiers in Microbiology 8, 553, 2017
152017
Development of an integration mutagenesis system in Lactobacillus gasseri
K Selle, YJ Goh, S O'Flaherty, TR Klaenhammer
Gut Microbes 5 (3), 326-525, 2014
152014
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20